Cargando…

Urinary epidermal growth factor predicts complete remission of proteinuria in Chinese children with IgA nephropathy

BACKGROUND: This study investigated the association between urinary epidermal growth factor (EGF) and complete remission (CR) of proteinuria in children with IgA nephropathy (IgAN). METHODS: We included 108 patients from the Registry of IgA Nephropathy in Chinese Children. The urinary EGF at the bas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Jianmei, Sun, Shuzhen, Zhang, Dongfeng, Mao, Jianhua, Xiao, Huijie, Yao, Yong, Wang, Fang, Yu, Lichun, Liu, Ling, Feng, Chunyue, Li, Chenglong, Su, Baige, Zhang, Hongwen, Liu, Xiaoyu, Xu, Ke, Ju, Wenjun, Zhong, Xuhui, Ding, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group US 2023
Materias:	Clinical Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382307/ https://www.ncbi.nlm.nih.gov/pubmed/36864281 http://dx.doi.org/10.1038/s41390-023-02542-0

Ejemplares similares

Seasonal proteinuria changes in IgA nephropathy patients after proteinuria remission
por: Inagaki, Koji, et al.
Publicado: (2017)

Tacrolimus decreases proteinuria in patients with refractory IgA nephropathy
por: Hu, Tingyang, et al.
Publicado: (2018)

Bortezomib for Reduction of Proteinuria in IgA Nephropathy
por: Hartono, Choli, et al.
Publicado: (2018)

Continuation of immunosuppressive treatment may be necessary in IgA nephropathy patients with remission of proteinuria: Evaluation by repeat renal biopsy
por: LUO, MIAN-NA, et al.
Publicado: (2014)

Remission of Proteinuria May Protect against Progression to Chronic Kidney Disease in Pediatric-Onset IgA Nephropathy
por: Suh, Jin-Soon, et al.
Publicado: (2020)

Effect of SGLT2 inhibitors on the proteinuria reduction in patients with IgA nephropathy
por: Dong, Yaping, et al.
Publicado: (2023)

Optimal Proteinuria Target for Renoprotection in Patients with IgA Nephropathy
por: Nam, Ki Heon, et al.
Publicado: (2014)

Hydroxychloroquine Reduces Proteinuria in Indian Patients With IgA Nephropathy
por: Bagchi, Soumita, et al.
Publicado: (2022)

Canagliflozin Markedly Decreased Proteinuria in a Patient With IgA Nephropathy
por: Aameish, Muhammad, et al.
Publicado: (2021)

Primary IgA nephropathy with nephrotic-range proteinuria in Chinese children
por: Zhao, Jing-Li, et al.
Publicado: (2021)

Randomized Phase 2 Trial of Telitacicept in Patients With IgA Nephropathy With Persistent Proteinuria
por: Lv, Jicheng, et al.
Publicado: (2022)

Serum Galactose-Deficient IgA1 Level Is Not Associated with Proteinuria in Children with IgA Nephropathy
por: Hastings, M. Colleen, et al.
Publicado: (2012)

Effects of Hydroxychloroquine on Proteinuria in IgA Nephropathy: A Systematic Review and Meta-Analysis
por: Zhang, Jialing, et al.
Publicado: (2021)

Malignant hypertension and nephrotic range proteinuria without hematuria: IgA nephropathy
por: Goswami, R. P., et al.
Publicado: (2013)

Corticosteroid Treatment Influences TA-Proteinuria and Renal Survival in IgA Nephropathy
por: Sarcina, Cristina, et al.
Publicado: (2016)

Severity of foot process effacement is associated with proteinuria in patients with IgA nephropathy
por: Lee, Ji-Hye, et al.
Publicado: (2020)

Comparison of the effects of hydroxychloroquine and corticosteroid treatment on proteinuria in IgA nephropathy: a case-control study
por: Yang, Ya-zi, et al.
Publicado: (2019)

Utility of remission criteria for the renal prognosis of IgA nephropathy
por: Matsuzaki, Keiichi, et al.
Publicado: (2021)

Comment on: Malignant hypertension and nephrotic range proteinuria without hematuria: IgA nephropathy
por: Nasri, H.
Publicado: (2014)

Significance of tonsillectomy combined with steroid pulse therapy for IgA nephropathy with mild proteinuria
por: Komatsu, Hiroyuki, et al.
Publicado: (2015)

Urinary Soluble CD163 Levels Predict IgA Nephropathy Remission Status
por: Gong, Shaomin, et al.
Publicado: (2021)

Immunosuppressive agents versus steroids in the treatment of IgA nephropathy-induced proteinuria: A meta-analysis
por: Liu, Yanli, et al.
Publicado: (2016)

Immunosuppressive agents versus steroids in the treatment of IgA nephropathy-induced proteinuria: A meta-analysis
por: Liu, Yanli, et al.
Publicado: (2019)

Outcomes of normotensive IgA nephropathy patients with mild proteinuria who have impaired renal function
por: Tan, Min, et al.
Publicado: (2019)

Author response on: Malignant hypertension and nephrotic range proteinuria without hematuria: IgA nephropathy
por: Goswami, R. P., et al.
Publicado: (2014)

Role of immunosuppressive therapy and predictors of therapeutic effectiveness and renal outcome in IgA nephropathy with proteinuria
por: Ruan, Yiping, et al.
Publicado: (2015)

Corticosteroids or immunosuppressants were not superior to supportive care in IgA nephropathy patients with mild proteinuria
por: Pei, Gaiqin, et al.
Publicado: (2020)

Randomized Phase II JANUS Study of Atacicept in Patients With IgA Nephropathy and Persistent Proteinuria
por: Barratt, Jonathan, et al.
Publicado: (2022)

Diagnosis and treatment of IgA nephropathy and IgA vasculitis nephritis in Chinese children
por: Zhong, Xuhui, et al.
Publicado: (2022)

High serum IgA/C3 ratio better predicts a diagnosis of IgA nephropathy among primary glomerular nephropathy patients with proteinuria ≤ 1 g/d: an observational cross-sectional study
por: Gong, Wen-yu, et al.
Publicado: (2019)

Proteinuria during Follow-Up Period and Long-Term Renal Survival of Childhood IgA Nephropathy
por: Kamei, Koichi, et al.
Publicado: (2016)

Long-term prognosis of IgA nephropathy presenting with minimal or no proteinuria: A single center experience
por: Imai, N., et al.
Publicado: (2016)

In Acute IgA Nephropathy, Proteinuria and Creatinine Are in the Spot, but Podocyturia Operates in Silence: Any Place for Amiloride?
por: Trimarchi, H., et al.
Publicado: (2017)

Spontaneous remission in adult patients with IgA nephropathy treated with conservative therapy
por: Sato, Hirotaka, et al.
Publicado: (2021)

Phenotypic spectrum and antialbuminuric response to angiotensin converting enzyme inhibitor and angiotensin receptor blocker therapy in pediatric Dent disease
por: Deng, Haiyue, et al.
Publicado: (2020)

Spectrum of Mutations in Pediatric Non-glomerular Chronic Kidney Disease Stages 2–5
por: Wang, Xiaoyuan, et al.
Publicado: (2021)

Prognostic factors of IgA nephropathy presenting with mild proteinuria at the time of diagnosis (a multicenter cohort study)
por: Shirai, Sayuri, et al.
Publicado: (2023)

Comparison between outcomes of IgA nephropathy with nephrotic-range proteinuria and nephrotic syndrome: do podocytes play a role?
por: Chen, Yizhen, et al.
Publicado: (2022)

Utility of non-HDL-C in predicting proteinuria remission of idiopathic membranous nephropathy: a retrospective cohort study
por: Dong, Lei, et al.
Publicado: (2021)

Clinical significance of massive proteinuria in primary IgA nephropathy with and without nephrotic syndrome: a single center cohort study
por: Hu, Ya, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_01jpjano6ge542ke8djscslsl1